Richmond, CA, United States of America

Angela R Brooks-Wilson

This inventor holds 4 USPTO granted patents. Top assignees: The University of British Columbia, Xenon Pharmaceuticals Inc., The Public Health Agency of Canada. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela R Brooks-Wilson. Retrieved from https://idiyas.com/inventor/angela-r-brooks-wilson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Vancouver, CA (2007)
  • Richmond, CA (2010 - 2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Angela R Brooks-Wilson: Innovator in Biotechnology

Introduction

Angela R Brooks-Wilson is a prominent inventor based in Richmond, CA (US). She has made significant contributions to the field of biotechnology, particularly in the areas of cholesterol regulation and viral genomics. With a total of 4 patents, her work has had a substantial impact on medical research and treatment options.

Latest Patents

One of her latest patents is titled "Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide." This invention features ABC1 nucleic acids and polypeptides that are crucial for diagnosing and treating abnormal cholesterol regulation. Additionally, it includes methods for identifying compounds that can modulate cholesterol levels in animals, including humans. Another notable patent is related to the "SARS virus nucleotide and amino acid sequences and uses thereof." This invention provides the genomic sequence of a putative coronavirus, the SARS virus, along with novel nucleic acid and amino acid sequences that can be utilized for diagnosis, prophylaxis, or therapy of various SARS virus-related disorders.

Career Highlights

Angela has worked with notable organizations such as Xenon Pharmaceuticals Inc. and the University of British Columbia. Her career reflects a strong commitment to advancing scientific knowledge and developing innovative solutions in healthcare.

Collaborations

Angela has collaborated with esteemed colleagues, including Michael R Hayden and Simon N Pimstone, further enhancing her contributions to the field.

Conclusion

Angela R Brooks-Wilson's work exemplifies the intersection of innovation and biotechnology. Her patents and collaborations continue to influence the landscape of medical research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…